7.77
0.44 (6.00%)
| Penutupan Terdahulu | 7.33 |
| Buka | 7.85 |
| Jumlah Dagangan | 165,167 |
| Purata Dagangan (3B) | 412,967 |
| Modal Pasaran | 256,922,048 |
| Harga / Buku (P/B) | 2.00 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -12.64 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.58% |
| Nisbah Semasa (MRQ) | 9.38 |
| Aliran Tunai Operasi (OCF TTM) | -62.95 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -36.83 M |
| Pulangan Atas Aset (ROA TTM) | -39.93% |
| Pulangan Atas Ekuiti (ROE TTM) | -74.83% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Lexeo Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.40 |
|
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 0.49% |
| % Dimiliki oleh Institusi | 91.48% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (Chardan Capital, 221.75%) | Beli |
| Median | 23.00 (196.01%) | |
| Rendah | 19.00 (Leerink Partners, 144.53%) | Beli |
| Purata | 22.33 (187.39%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 7.69 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 14 Nov 2024 | 23.00 (196.01%) | Beli | 7.78 |
| 31 Oct 2024 | 21.00 (170.27%) | Beli | 7.90 | |
| Chardan Capital | 13 Nov 2024 | 25.00 (221.75%) | Beli | 7.64 |
| 30 Oct 2024 | 23.00 (196.01%) | Beli | 8.28 | |
| Leerink Partners | 13 Nov 2024 | 19.00 (144.53%) | Beli | 7.64 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| TOWNSEND RICHARD NOLAN | - | 8.36 | -2,500 | -20,900 |
| Jumlah Keseluruhan Kuantiti Bersih | -2,500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -20,900 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 8.36 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TOWNSEND RICHARD NOLAN | Pegawai | 10 Dec 2024 | Jual automatik (-) | 2,500 | 8.36 | 20,900 |
| TOWNSEND RICHARD NOLAN | Pegawai | 10 Dec 2024 | Pelaksanaan pilihan | 2,500 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |